SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-067253
Filing Date
2023-03-10
Accepted
2023-03-10 12:28:54
Documents
12
Period of Report
2023-03-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d483112d8k.htm   iXBRL 8-K 20713
  Complete submission text file 0001193125-23-067253.txt   140977

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA scph-20230310.xsd EX-101.SCH 2881
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20230310_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20230310_pre.xml EX-101.PRE 11282
6 EXTRACTED XBRL INSTANCE DOCUMENT d483112d8k_htm.xml XML 3345
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 23722679
SIC: 2834 Pharmaceutical Preparations